Biotech Company Says MRNA Detection Patent Should Be Canceled
ALEXANDRIA, Va. — The maker of the molecular profiling “Visium” system says in a Sept. 25 petition for inter partes review (IPR) that a patent directed to the spatial detection of...To view the full article, register now.
Already a subscriber? Click here to view full article